| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 32.711 | 63.880 | 81.346 | 86.456 | 70.262 | 0 | 8.485 | 14.032 |
| Total Income - EUR | - | - | 32.711 | 63.880 | 81.346 | 86.456 | 70.262 | 0 | 14.983 | 41.849 |
| Total Expenses - EUR | - | - | 8.146 | 11.176 | 22.280 | 13.031 | 5.704 | 1.788 | 27.249 | 46.538 |
| Gross Profit/Loss - EUR | - | - | 24.566 | 52.704 | 59.067 | 73.424 | 64.558 | -1.788 | -12.266 | -4.688 |
| Net Profit/Loss - EUR | - | - | 24.238 | 52.065 | 58.615 | 72.656 | 64.136 | -1.788 | -12.335 | -4.688 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Neurokinetik Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 214.755 | 185.737 |
| Current Assets | - | - | 31.434 | 83.134 | 133.484 | 207.454 | 229.565 | 227.419 | 217.625 | 218.406 |
| Inventories | - | - | 89 | 87 | 85 | 84 | 82 | 82 | 82 | 200 |
| Receivables | - | - | 32.711 | 18.795 | 90.382 | 151.908 | 143.388 | 145.049 | 217.615 | 215.268 |
| Cash | - | - | -1.366 | 64.252 | 43.016 | 55.462 | 86.096 | 82.288 | -71 | 2.938 |
| Shareholders Funds | - | - | 24.282 | 75.945 | 133.089 | 184.615 | 228.486 | 227.406 | -4.094 | -8.775 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 7.152 | 7.189 | 395 | 22.838 | 1.080 | 13 | 243.162 | 248.504 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 193.312 | 164.414 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Neurokinetik Plus Srl